Compounds > 5,7-dihydroxytryptamine
Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Striatonigral Atrophy

5,7-dihydroxytryptamine has been researched along with Striatonigral Atrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, RW; Brus, R; Kostrzewa, JP; Kostrzewa, RM; Nowak, P1

Reviews

1 review(s) available for 5,7-dihydroxytryptamine and Striatonigral Atrophy

ArticleYear
Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability.
    Neurotoxicity research, 2008, Volume: 14, Issue:2-3

    Topics: 5,7-Dihydroxytryptamine; Age Factors; Animals; Animals, Newborn; Behavior, Animal; Denervation; Oxidopamine; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Striatonigral Degeneration

2008